Clinical Trial Update: Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pembrolizumab, trastuzumab, and the FLOT regimen as perioperative therapy for localized HER2-positive esophagogastric adenocar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• DOCETAXEL (DOCETAXEL)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)
• Pembrolizumab (Keytruda) (pembrolizumab)
• Trastuzumab (Herceptin) (trastuzumab)

Snippet

Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Conditions: Esophagogastric Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING